COVID-19 and Acute Invasive Fungal Rhinosinusitis

Al-Azhar University

Status: Completed

Conditions: Covid19

Treatments: Diagnostic Test: Fungal rhinosinusitis

Study type: Observational

Funder types: Other

Identifiers

NCT04809480

20- 11- 002

Details and patient eligibility

About

Data for acute invasive rhinosinusitis was obtained from the Otorhinolaryngology departments at our tertiary hospital at the period from January 2017 to December 2020. Then the risk factors of comorbid diseases and fungal types between post-Covid-19 and non-Covid-19 groups regarding the incidence of invasive rhinosinusitis are compared.

Enrollment: 56 patients

Sex: All

Ages: 15 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients of any age and sex. invasive rhinosinusoitis diagnosis based on clinical , endoscopic diagnosis
• Positive findings for acute sinusitis on sinus computed tomography (CT) scan in addition to fungal determination by histopathological examination of specimen of affected tissues for detection of the type of fungi.
• Positive PCR was confirmed from the patient's files at the isolation hospitals for COVID 19 group.

Exclusion criteria

• Patients who completed management outside our hospital

Trial design

56 participants in 2 patient groups

Non-COVID19 patients

Description:

All acute invasive fungal rhinosinusitis patients managed in our hospital from January 2017 up to February 2020

Treatment:

Diagnostic Test: Fungal rhinosinusitis

COVID19 patients

Description:

All acute invasive fungal rhinosinusitis patients managed in our hospital from February 2020 up to December 2020 with positive COVID19 PCR test

Treatment:

Diagnostic Test: Fungal rhinosinusitis